126 related articles for article (PubMed ID: 8277519)
1. Designing a biological monitoring program to assess community exposure to chromium: conclusions of an expert panel.
Anderson RA; Colton T; Doull J; Marks JG; Smith RG; Bruce GM; Finley BL; Paustenbach DJ
J Toxicol Environ Health; 1993 Dec; 40(4):555-83. PubMed ID: 8277519
[TBL] [Abstract][Full Text] [Related]
2. Community exposure and medical screening near chromium waste sites in New Jersey.
Fagliano JA; Savrin J; Udasin I; Gochfeld M
Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 2):S13-22. PubMed ID: 9380833
[TBL] [Abstract][Full Text] [Related]
3. Lead contamination in Uruguay: the "La Teja" neighborhood case.
Mañay N; Cousillas AZ; Alvarez C; Heller T
Rev Environ Contam Toxicol; 2008; 195():93-115. PubMed ID: 18418955
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the human health risks posed by exposure to chromium-contaminated soils.
Sheehan PJ; Meyer DM; Sauer MM; Paustenbach DJ
J Toxicol Environ Health; 1991 Feb; 32(2):161-201. PubMed ID: 1995927
[TBL] [Abstract][Full Text] [Related]
5. Designing a biological monitoring program to assess community exposure to chromium.
Gochfeld M; Lioy P
J Toxicol Environ Health; 1995 Jan; 44(1):125-8; author reply 128-34. PubMed ID: 7823327
[No Abstract] [Full Text] [Related]
6. Biomonitoring for chromium and arsenic in timber treatment plant workers exposed to CCA wood Preservatives.
Cocker J; Morton J; Warren N; Wheeler JP; Garrod AN
Ann Occup Hyg; 2006 Jul; 50(5):517-25. PubMed ID: 16551676
[TBL] [Abstract][Full Text] [Related]
7. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of chromium by humans following ingestion of chromium picolinate. Implications for biomonitoring.
Gargas ML; Norton RL; Paustenbach DJ; Finley BL
Drug Metab Dispos; 1994; 22(4):522-9. PubMed ID: 7956725
[TBL] [Abstract][Full Text] [Related]
9. An assessment and quantitative uncertainty analysis of the health risks to workers exposed to chromium contaminated soils.
Paustenbach DJ; Meyer DM; Sheehan PJ; Lau V
Toxicol Ind Health; 1991 May; 7(3):159-96. PubMed ID: 1949057
[TBL] [Abstract][Full Text] [Related]
10. Biomonitoring equivalents: a screening approach for interpreting biomonitoring results from a public health risk perspective.
Hays SM; Becker RA; Leung HW; Aylward LL; Pyatt DW
Regul Toxicol Pharmacol; 2007 Feb; 47(1):96-109. PubMed ID: 17030369
[TBL] [Abstract][Full Text] [Related]
11. Field evaluation of a sampling and analytical method for environmental levels of airborne hexavalent chromium.
Sheehan P; Ricks R; Ripple S; Paustenbach D
Am Ind Hyg Assoc J; 1992 Jan; 53(1):57-68. PubMed ID: 1590220
[TBL] [Abstract][Full Text] [Related]
12. Biomonitoring for environmental exposures to arsenic.
Orloff K; Mistry K; Metcalf S
J Toxicol Environ Health B Crit Rev; 2009 Aug; 12(7):509-24. PubMed ID: 20183531
[TBL] [Abstract][Full Text] [Related]
13. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
14. Environmental and human exposure assessment monitoring of communities near an abandoned mercury mine in the Philippines: a toxic legacy.
Maramba NP; Reyes JP; Francisco-Rivera AT; Panganiban LC; Dioquino C; Dando N; Timbang R; Akagi H; Castillo MT; Quitoriano C; Afuang M; Matsuyama A; Eguchi T; Fuchigami Y
J Environ Manage; 2006 Oct; 81(2):135-45. PubMed ID: 16949727
[TBL] [Abstract][Full Text] [Related]
15. Urinary chromium as a biological marker of environmental exposure: what are the limitations?
Paustenbach DJ; Panko JM; Fredrick MM; Finley BL; Proctor DM
Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 2):S23-34. PubMed ID: 9380834
[TBL] [Abstract][Full Text] [Related]
16. Urinary excretion of chromium following ingestion of chromite-ore processing residues in humans: implications for biomonitoring.
Gargas ML; Norton RL; Harris MA; Paustenbach DJ; Finley BL
Risk Anal; 1994 Dec; 14(6):1019-24. PubMed ID: 7846309
[TBL] [Abstract][Full Text] [Related]
17. Human health risk and exposure assessment of chromium (VI) in tap water.
Paustenbach DJ; Finley BL; Mowat FS; Kerger BD
J Toxicol Environ Health A; 2003 Jul; 66(14):1295-339. PubMed ID: 12851114
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of exposure in community settings.
Metcalf SW; Orloff KG
J Toxicol Environ Health A; 2004 Apr 23-May 28; 67(8-10):715-26. PubMed ID: 15192864
[TBL] [Abstract][Full Text] [Related]
19. [Biological monitoring in chromium-plating industry].
Madsen SW; Krue S; Bonde JP
Ugeskr Laeger; 1992 May; 154(22):1564-8. PubMed ID: 1631984
[TBL] [Abstract][Full Text] [Related]
20. Chemicals of emerging concern in the Great Lakes Basin: an analysis of environmental exposures.
Klecka G; Persoon C; Currie R
Rev Environ Contam Toxicol; 2010; 207():1-93. PubMed ID: 20652664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
